文献速递青光眼

兔眼和小鼠眼结膜下淋巴管对VEGFC和抗代谢药物的反应

Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

该研究在兔和小鼠两种动物模型中,用不同方法表征并药物干预结膜下淋巴管。兔眼结膜下注射VEGFC可增加淋巴管mRNA和蛋白(P=0.004-0.04),但不影响血管(P=0.77-0.84)。Prox1-tdTomato转基因小鼠中,VEGFC增加淋巴管分支和长度(P≤0.001-0.004),而抗代谢药物在长方案中作用相反(P≤0.001-0.043)。

要点

  • 兔眼结膜下淋巴管与滤过泡相关流出通路重叠,且无鼻颞侧偏好。
  • 兔眼结膜下注射VEGFC增加淋巴管标志物mRNA和蛋白,对血管无显著影响。
  • 小鼠长方案中抗代谢药物减少淋巴管分支和长度,与VEGFC作用相反。

核心结论

  • 在两种动物模型中使用不同方法学,结膜下淋巴管对VEGFC和抗代谢药物均有药理学反应,这些结果可能对滤过泡青光眼手术或眼部给药具有重要意义。

研究设计与样本

  • 兔眼接受结膜下注射台盼蓝或可固定荧光葡聚糖,量化滤过泡相关流出通路,并行血管特异性标志物免疫荧光。
  • 兔眼结膜下注射VEGFC,用RT-PCR和Western blot评估mRNA和蛋白。
  • 小鼠研究使用Prox1-tdTomato转基因报告小鼠,结膜下注射条件包括不注射、平衡盐溶液(BSS)、VEGFC、5-氟尿嘧啶(5FU)和两种浓度的丝裂霉素-C(MMC),分短方案和长方案两种注射方案。

主要发现

  • 兔眼显示清晰的滤过泡相关结膜下流出通路,与血管不同且无鼻颞侧偏好。
  • 兔眼结膜下VEGFC增加淋巴管mRNA或蛋白(P=0.004-0.04),但不影响血管(P=0.77-0.84)。
  • Prox1-tdTomato转基因报告小鼠显示天然荧光淋巴管。
  • 小鼠结膜下VEGFC增加淋巴管分支和长度(P≤0.001-0.004),而抗代谢药物在长方案中作用相反(P≤0.001-0.043)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To characterize and pharmacologically influence subconjunctival lymphatics in rabbit and mouse eyes. METHODS: Rabbits received subconjunctival injections of trypan blue or fixable fluorescent dextrans. Bleb-related outflow pathways were quantified. Immunofluorescence for vessel-specific markers (lymphatics [podoplanin and LYVE-1] and blood vessels [CD31]) were performed in native rabbit conjunctiva and after fixable fluorescent dextran injection. Vascular endothelial cell growth factor-C (VEGFC) was injected subconjunctivally in rabbits. mRNA and protein were assessed for the above markers using RT-PCR and Western blot. Alternatively, mouse studies used Prox1-tdTomato transgenic reporter mice. Subconjunctival injection conditions included: no injection, balanced salt solution (BSS), VEGFC, 5-fluorouracil (5FU) and two concentrations of mitomycin-C (MMC). Two mouse injection protocols (short and long) with different follow-up times and number of injections were performed. Mouse eyes were enucleated, flat mounts created, and subconjunctival branching and length assessed. RESULTS: Rabbit eyes demonstrated clear bleb-related subconjunctival outflow pathways that were distinct from blood vessels and were without nasal/temporal predilection. Immunofluorescence against vessel-specific markers showed lymphatics and blood vessels in rabbit conjunctiva, and these lymphatics overlapped with bleb-related subconjunctival outflow pathways. Subconjunctival VEGFC increased lymphatic (P = 0.004-0.04) but not blood vessel (P = 0.77-0.84) mRNA or protein in rabbits. Prox1-tdTomato transgenic reporter mice demonstrated natively fluorescent lymphatics. Subconjunctival VEGFC increased murine lymphatic branching and length (P ≤ 0.001-0.004) while antimetabolites (P ≤ 0.001-0.043) did the opposite for the long protocol. DISCUSSION: Subconjunctival lymphatics are pharmacologically responsive to both VEGFC and antimetabolites in two animal models studied using different methodologies. These results may be important for bleb-forming glaucoma surgeries or ocular drug delivery.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lee JY, Wu J, Liu Y, et al. Subconjunctival Lymphatics Respond to VEGFC and Anti-Metabolites in Rabbit and Mouse Eyes. Invest Ophthalmol Vis Sci. 2022. PMID: 36166215. doi:10.1167/iovs.63.10.16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。